Answers are grounded in this paper and cite their sources.
Here, we present a short overview of our implementation of label-free digital pathology by infrared (IR) imaging. We address the major issues to overcome for clinical translation. First, we elucidate that label-free IR imaging not only identifies cancer in tissue sections but also is even able to provide differential diagnostics as exemplified for colorectal and lung cancer. We obtained sensitivities and specificities far above 90% as compared to the gold standard histopathology. The information is obtained label-free, automated and observer independent. We showed that the spectral patterns observed in the infrared corresponds directly to protein alterations in tissue. This was achieved by integrating IR imaging with laser capture microdissection and subsequent proteome analysis. Furthermore, we demonstrated that IR imaging could replace immunohistochemical marker panels for differential diagnosis. Following one of the most important steps towards translation was the reduction of the measurement time, which now matches the time consumed for immediate diagnostics. Finally, we integrate deep neural networks for the automated annotation. All hurdles has been overcome and label-free digital pathology is ready to validate now the approach in clinically relevant unmet medical needs. This will facilitate acceptance of the approach by clinicians and pave the road for clinical translation.
No takes yet. Share an insight, caveat, or question.
Großerueschkamp et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: